drugset / Trial / NCT02379663
Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This prospective study compares an oral direct factor Xa inhibitor with LMWH for thromboprophylaxis in the patients undergoing THA.
Timeline
- Start
- 2012-01
- Primary completion
- 2013-01
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Enoxaparin sodium | Other / unclassified | 40 mg | Subcutaneous |
| Comparator | Rivaroxaban | Other / unclassified | 10 mg | Oral |